Entero Therapeutics names new interim CEO after leadership change

Go back to Entero Therapeutics names new interim CEO after leadership change
(NASDAQ: ENTO) Delayed: 2.99 --0 (-0%)
Previous Close $2.99    52 Week High
Open $2.99    52 Week Low
Day High $2.99    P/E N/A 
Day Low $2.99    EPS
Volume 794